Acromegaly Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
The Acromegaly clinical trial market research report provides an overview of the Acromegaly clinical trials scenario. The report provides top-line data relating to the clinical trials on Acromegaly. The Acromegaly, 2022 report includes an overview of trial numbers and their average enrollment in top countries conducted globally. The clinical trials report also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type.
Regional and Country-Wise Outlook of the Acromegaly Clinical Trials Market
Most clinical trials for Acromegaly were conducted in Europe, followed by North America, Asia Pacific, South and Central America, and the Middle East and Africa.
In a country-wise analysis, the US has the highest number of Acromegaly clinical trials as of August 2022, followed by Italy, the UK, Germany, Poland, France, the Netherlands, Hungary, Australia, and Brazil. The US also has the highest average patient enrollment of Acromegaly clinical trials.
Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the UK has the highest proportion of Acromegaly to Hormonal Disorders clinical trials as of August 2022.
Likewise, among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Brazil has the highest proportion of Acromegaly to Hormonal Disorders clinical trials as of August 2022. Moreover, among the E7 countries, most clinical trials conducted on Acromegaly were in China.
Acromegaly Clinical Trials Analysis, By Regions
For more regional insights of the Acromegaly Clinical Trials Market , download a free report sample
Acromegaly Clinical Trials Market Segmentation by Sponsor Types
The sponsor types in the Acromegaly clinical trials market are company, institution, and government. More than half of the clinical trials have been sponsored by company.
Acromegaly Clinical Trials Market Analysis, by Sponsor Types
For more insights on Acromegaly Clinical Trials Market sponsor types, download a free report sample
Competitive Landscape
The leading companies in the Acromegaly clinical trials market are Ipsen SA, Novartis AG, Pfizer Inc, Crinetics Pharmaceuticals Inc, Sandberg Development AB, Amryt Pharma Plc, Accelsiors CRO & Consultancy Services, Midatech Pharma Plc, Antisense Therapeutics Ltd, Aspireo Pharmaceuticals Ltd. Ipsen SA has conducted highest number of clinical trials in the Acromegaly clinical trials market.
Acromegaly Clinical Trials Market Analysis, by Leading Companies
To know more about the leading companies in the Acromegaly Clinical Trials Market, download a free report sample
Acromegaly Clinical Trials Market Report Overview
| Key Regions | Europe, North America, Asia Pacific, the Middle East, and Africa, and South and Central America |
| Key Countries | The US, Italy, The UK, Germany, Poland, France, The Netherlands, Hungary, Australia, and Brazil |
| Key Sponsor Types | Company, Institution, and Government |
| Leading Companies | Ipsen SA, Novartis AG, Pfizer Inc, Crinetics Pharmaceuticals Inc, Sandberg Development AB, Amryt Pharma Plc, Accelsiors CRO & Consultancy Services, Midatech Pharma Plc, Antisense Therapeutics Ltd, Aspireo Pharmaceuticals Ltd |
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Novartis AG
Pfizer Inc
Crinetics Pharmaceuticals Inc
Sandberg Development AB
Amryt Pharma Plc
Accelsiors CRO & Consultancy Services
Midatech Pharma Plc
Antisense Therapeutics Ltd
Aspireo Pharmaceuticals Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key regions in the Acromegaly clinical trials market?
The key regions in the Acromegaly clinical trials market are Europe, North America, Asia Pacific, the Middle East, and Africa, and South and Central America.
-
WhichW are the key countries in the Acromegaly clinical trials market?
The key countries in the Acromegaly clinical trials market are the US, Italy, the UK, Germany, Poland, France, the Netherlands, Hungary, Australia, and Brazil.
-
What are the key sponsor types in the Acromegaly clinical trials market?
The key sponsor types in the Acromegaly clinical trials market are company, institution, and government.
-
Which are the leading companies in the Acromegaly clinical trials market?
The leading companies in the Acromegaly clinical trials market are Ipsen SA, Novartis AG, Pfizer Inc, Crinetics Pharmaceuticals Inc, Sandberg Development AB, Amryt Pharma Plc, Accelsiors CRO & Consultancy Services, Midatech Pharma Plc, Antisense Therapeutics Ltd, Aspireo Pharmaceuticals Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Hormonal Disorders reports


